Lenacapavir (LEN) is an antiviral medication used to treat and prevent HIV/AIDS and was first approved for individuals with ...

What are lawmakers doing about this during the 2026 legislative session?

Opinion: "While the obstacles we face may be significant, Lenacapavir represents a monumental breakthrough in the fight ...

After four decades of hard-won progress toward curbing the HIV epidemic, the face of the disease is changing.

Now, Gilead has conducted an analysis of a phenomenon that can undermine all infectious disease therapies, including lenacapavir—HIV’s ability to evolve resistance to the breakthrough antiviral.

The global Kaposi’s Sarcoma market is expanding due to the HIV/AIDS prevalence, improved oncology infrastructure, and advancements in targeted and immunotherapeutic drugs. Kaposi’s Sarcoma, a tumor ...

New pilot partnership links at-home HIV screening with clinical prevention and treatment services across Ontario. TORONTO, ON ...

For most of its history, the US military has refused to recruit HIV-positive soldiers. The Trump administration appears to be ...

Advances in HIV treatment allow for safe intimacy and marriage ...

New guidelines update ART choices, endorse long-acting injectables, refine infant feeding advice, and prioritise shorter TB ...

The World Health Organization (WHO) has released updated recommendations on HIV clinical management providing new and revised ...

KUALA LUMPUR: An average of 3,169 new HIV cases were recorded annually between 2018 to 2025, the Dewan Rakyat was told. The ...